Sign in
4

Changes in Ownership

TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-22-014471

EVP, Chief Financial Officer acquired 18,430 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Kalif Eliyahu Sharon · EVP, Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2022-02-28 Exercise or conversion : show line 1 in the form +18,430 43,489 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-02-28 Exercise or conversion : show line 2 in the form Restricted Share Units −18,430 36,860 D
Loading xslF345X03/doc4.xml…